Comparison of three-year outcomes after coronary stenting versus coronary artery bypass grafting in patients with multivessel coronary disease, including involvement of the left anterior descending coronary artery proximally (a subanalysis of the arterial revascularization therapies study trial)

https://doi.org/10.1016/j.amjcard.2004.05.028Get rights and content

The long-term effect of stents in patients with multivessel disease involving the proximal left anterior descending artery was investigated. At 3 years, there was no difference in the combined incidence of death, stroke, and myocardial infarction in either group, but the need for repeat revascularization was more frequent in the group with stenting than in the group with coronary artery bypass grafting.

References (18)

There are more references available in the full text version of this article.

Cited by (10)

  • 5-Year Clinical Outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the Sirolimus-Eluting Stent in the Treatment of Patients With Multivessel De Novo Coronary Artery Lesions

    2010, Journal of the American College of Cardiology
    Citation Excerpt :

    ARTS II was a multicenter, nonrandomized, open-label trial designed to compare the safety and efficacy of the SES in patients with de novo multivessel coronary artery disease, with the surgical group of ARTS I acting as a historical control (10–16).

View all citing articles on Scopus

This study was supported by a grant from Cordis Corporation, a Johnson & Johnson, Inc., Company, New Brunswick, New Jersey.

View full text